Medox Tutors Limited

	Page
Company Information	1
Accountants' Report	2
Statement of Financial Position	3—4
Notes to the Financial Statements	5—10

Page 1

Page 2

Accountants' Report

For The Year Ended 31 December 2024

Accountants' Report

Chartered Accountants' report to the directors on the preparation of the unaudited statutory accounts of Medox Tutors Limited For The Year Ended 31 December 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Medox Tutors Limited for the year ended 31 December 2024 which comprise the Income Statement, the Statement of Financial Position and the related notes from the company's accounting records and from information and explanations you have given to us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the directors of Medox Tutors Limited , as a body, in accordance with the terms of our engagement letter dated . Our work has been undertaken solely to prepare for your approval the accounts of Medox Tutors Limited and state those matters that we have agreed to state to the directors of Medox Tutors Limited , as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Medox Tutors Limited and its directors, as a body, for our work or for this report.

It is your duty to ensure that Medox Tutors Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of Medox Tutors Limited . You consider that Medox Tutors Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit of the accounts of Medox Tutors Limited . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.

Signed

Sterling Accounting Solutions Ltd

23/09/2025

Sterling Accounting Solutions Ltd

Chartered Accountants

SAS House

Chipperfield Road

Kings Langley

Hertfordshire

WD4 9JB

Page 2

Page 3

Medox Tutors Limited

Statement of Financial Position

As At 31 December 2024

Statement of Financial Position

Registered number: 09622983

		2024		2023
	Notes	£	£	£	£
FIXED ASSETS
Intangible Assets	4		39,448		55,896
Tangible Assets	5		65,152		74,348

			104,600		130,244
CURRENT ASSETS
Debtors	6	1,846,383		289,372
Cash at bank and in hand		706,325		1,254,049

		2,552,708		1,543,421
Creditors: Amounts Falling Due Within One Year	7	(1,030,688 )		(416,482 )

NET CURRENT ASSETS (LIABILITIES)			1,522,020		1,126,939

TOTAL ASSETS LESS CURRENT LIABILITIES			1,626,620		1,257,183

Creditors: Amounts Falling Due After More Than One Year	8		(61,799 )		(78,896 )

PROVISIONS FOR LIABILITIES
Deferred Taxation			(16,288 )		(18,587 )

NET ASSETS			1,548,533		1,159,700

CAPITAL AND RESERVES
Called up share capital	11		100		100
Income Statement			1,548,433		1,159,600

SHAREHOLDERS' FUNDS			1,548,533		1,159,700

Page 3

Page 4

Medox Tutors Limited

Statement of Financial Position (continued)

As At 31 December 2024

For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income Statement.

On behalf of the board

Rohan Agarwal Director	Ludovico Callerio Director
23/09/2025

The notes on pages 5 to 10 form part of these financial statements.

Page 4

Page 5

Medox Tutors Limited

Notes to the Financial Statements

For The Year Ended 31 December 2024

Notes to the Financial Statements

1. General Information

Medox Tutors Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09622983 . The registered office is SAS House, Chipperfield Road, Kings Langley, WD4 9JB.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

These financial statements have been prepared in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland" ("FRS 102") and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Rendering of services

Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2.3. Research and Development

Development expenditure incurred is capitalised as an intangible asset only when all of the

following criteria are met:

• It is technically feasible to complete the intangible asset so that it will be available for use or sale;

• There is the intention to complete the intangible asset and use or sell it;

• There is the ability to use or sell the intangible asset;

• The use or sale of the intangible asset will generate probable future economic benefits;

• There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and

• The expenditure attributable to the intangible asset during its development can be measured reliably.

Expenditure that does not meet the above criteria is expensed as incurred.

It is amortised to income statement over its estimated economic life of 5 years.

Page 5

Page 6

Medox Tutors Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2024

2.4. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery	20% reducing balance
Motor Vehicles	8 years straight line

2.5. Leasing and Hire Purchase Contracts

Assets obtained under finance leases are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the income statement so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to the income statement as incurred.

2.6. Financial Instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.

All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Page 6

Page 7

Medox Tutors Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2024

2.7. Foreign Currencies

Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.

2.8. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.

2.9. Pensions

The company operates a defined pension contribution scheme. Contributions are charged to the income statement as they become payable in accordance with the rules of the scheme.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 11 (2023: 11)

Page 7

Page 8

Medox Tutors Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2024

4. Intangible Assets

	Development Costs
	£
Cost
As at 1 January 2024	82,240

As at 31 December 2024	82,240

Amortisation
As at 1 January 2024	26,344
Provided during the period	16,448

As at 31 December 2024	42,792

Net Book Value
As at 31 December 2024	39,448

As at 1 January 2024	55,896

5. Tangible Assets

	Plant & Machinery	Motor Vehicles	Total
	£	£	£
Cost
As at 1 January 2024	11,467	69,950	81,417
Additions	582	-	582

As at 31 December 2024	12,049	69,950	81,999

Depreciation
As at 1 January 2024	6,340	729	7,069
Provided during the period	1,034	8,744	9,778

As at 31 December 2024	7,374	9,473	16,847

Net Book Value
As at 31 December 2024	4,675	60,477	65,152

As at 1 January 2024	5,127	69,221	74,348

Page 8

Page 9

Medox Tutors Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2024

6. Debtors

	2024	2023
	£	£
Due within one year
Trade debtors	81,290	9,300
Other debtors	66,193	27,187
Directors' loan accounts	-	2,069
Amounts owed by group undertakings	1,698,900	250,816

	1,846,383	289,372

7. Creditors: Amounts Falling Due Within One Year

	2024	2023
	£	£
Net obligations under finance lease and hire purchase contracts	7,097	5,221
Trade creditors	6,669	13,086
Bank loans and overdrafts	10,000	10,000
Corporation tax	(85 )	35
Other creditors	1,006,628	388,140
Directors' loan accounts	379	-

	1,030,688	416,482

8. Creditors: Amounts Falling Due After More Than One Year

	2024	2023
	£	£
Net obligations under finance lease and hire purchase contracts	57,632	64,729
Bank loans	4,167	14,167

	61,799	78,896

9. Obligations Under Finance Leases and Hire Purchase

	2024	2023
	£	£
The future minimum finance lease payments are as follows:
Not later than one year	7,097	5,221
Later than one year and not later than five years	57,632	64,729

	64,729	69,950

	64,729	69,950

Page 9

Page 10

Medox Tutors Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2024

10. Provisions for Liabilities


	Deferred Tax	Total
	£	£
As at 1 January 2024	18,587	18,587
Deferred taxation	(2,299 )	(2,299 )

Balance at 31 December 2024	16,288	16,288

11. Share Capital

	2024	2023
Allotted, called up and fully paid	£	£
1,000,000 Ordinary Shares of £ 0.0001 each	100	100

12. Pension Commitments

The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. At the statement of financial position date unpaid contributions of £3,705 (2023: £2,603) were due to the fund. They are included in Other Creditors.

13. Related Party Transactions

At the year end £58,839 (2023: £10,649) was owed from companies under common control. This amount is included within other debtors.

At the year end £154,549 (2023: £367) was owed to companies under common control. This amount is included within other creditors.

At the year end £1,698,900 (2023: £250,966) was owed from it's parent company. This amount is included within amounts owed by group undertakings.

14. Parent Undertaking and Controlling Party

The company's immediate and parent undertaking is Testbusters UK Holdings Ltd . Testbusters UK Holdings Ltd was incorporated in England and Wales.

The ultimate controlling party is Testbusters SRL who controls 100% of the shares of Testbusters UK Holdings Ltd .

Page 10

Directors	Testbusters UK Holdings Ltd
	Rohan Agarwal
	Ludovico Callerio

Company Number	09622983

Registered Office	SAS House
	Chipperfield Road
	Kings Langley
	WD4 9JB

Accountants	Sterling Accounting Solutions Ltd
	Chartered Accountants
	SAS House
	Chipperfield Road
	Kings Langley
	Hertfordshire
	WD4 9JB